Junko Ohkanda Selected Research

cdc25 Phosphatases

1/2021

Design, synthesis, and functional evaluation of triazine-based bivalent agents that simultaneously target the active site and hot spot of phosphatase Cdc25B.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Junko Ohkanda Research Topics

Disease

7	Neoplasms (Cancer) 01/2021 - 03/2002
2	Chagas Disease (American Trypanosomiasis) 06/2009 - 12/2003
1	Melanoma (Melanoma, Malignant) 09/2013
1	Hypoxia (Hypoxemia) 09/2012
1	Pancreatic Neoplasms (Pancreatic Cancer) 09/2012
1	African Trypanosomiasis (Nagana) 01/2004
1	Carcinogenesis 12/2003
1	Breast Neoplasms (Breast Cancer) 12/2003

Drug/Important Bio-Agent (IBA)

2	Pharmaceutical PreparationsIBA 12/2003 - 12/2003
2	geranylgeranyltransferase type-I (protein geranylgeranyltransferase)IBA 12/2003 - 03/2002
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2021
1	cdc25 PhosphatasesIBA 01/2021
1	LipidsIBA 10/2019
1	Adenosine Triphosphate (ATP)IBA 09/2013
1	cotylenin AIBA 09/2013
1	ISIR-042IBA 09/2012
1	fusicoccinIBA 09/2012
1	Gemcitabine FDA Link 09/2012
1	ImidazolesIBA 06/2009
1	posaconazole FDA Link 06/2009
1	LanosterolIBA 06/2009
1	PeptidomimeticsIBA 02/2006
1	GGTI-2154IBA 12/2003
1	Farnesyltranstransferase (Farnesyltransferase)IBA 12/2003
1	Proteins (Proteins, Gene)FDA Link 12/2003
1	Small Molecule LibrariesIBA 03/2002
1	ras ProteinsIBA 03/2002
1	EnzymesIBA 03/2002

Therapy/Procedure

3	Therapeutics 10/2019 - 01/2004
1	Aftercare (After-Treatment) 12/2003